Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories Limited’s recent financial review has been completed, with no material modifications required for the interim financial statements to comply with International Accounting Standards. The review, less extensive than a full audit, confirmed the company’s interim financials are in line with previous audited results. This news suggests a stable financial position for the company as of June 30, 2024.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
